The House Judiciary Committee has subpoenaed a former Pfizer executive who is considered central to its investigation into an ...

(Reuters) -The U.S. House Judiciary Committee on Monday subpoenaed a former Pfizer executive after he declined to voluntarily ...

Pfizer's hemophilia therapy, Hympavzi, met the main goal of a late-stage study in patients with certain types of antibodies, ...

A former Pfizer scientist was subpoenaed Monday by House Republicans over allegations that senior executives at the pharma ...

House Judiciary Chair Jim Jordan subpoenaed Dr. Philip Dormitzer after he refused to testify in the 2020 vaccine delay probe, ...

Chairman Jim Jordan subpoenaed former Pfizer executive Dr. Philip Dormitzer for an investigation into delayed COVID-19 ...

Pfizer insists that the discontinuation of the Phase II study was due to recruitment difficulties and was not linked to ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...

Pfizer's revenue slump is temporary. New launches and Seagen integration drive 2025 growth. Read here for an investment ...

Pfizer PFE has committed significant resources for the development of treatments in the fields of oncology, internal medicine ...

The House Judiciary Committee subpoenaed a former Pfizer Inc. executive, demanding he address allegations of deliberately ...

Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its ...